STOCK TITAN

Vireo Growth Inc. to Release Fourth Quarter and Full Year 2025 Results on March 17, 2026

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
earnings date

Vireo Growth (OTCQX: VREOF) will release fourth quarter and full year 2025 financial results on Tuesday, March 17, 2026, before market open. Management will host a conference call the same day at 8:00 a.m. ET (7:00 a.m. CT) to discuss results and answer investor questions.

Dial-in details: 1-800-715-9871 (US/Canada) or 1-646-307-1963 (International), conference ID 9471311. A live audio webcast will be available in the company’s Investor Relations Events & Presentations section at the provided Q4 events link.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – VREOF

-2.95%
1 alert
-2.95% News Effect

On the day this news was published, VREOF declined 2.95%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its fourth quarter and full fiscal year ended December 31, 2025 on Tuesday, March 17, 2026, before the market opens.

Vireo Growth management will host a conference call with the investment community that same day, Tuesday, March 17, 2026, at 8:00 a.m. ET (7:00 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 9471311.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link:
https://events.q4inc.com/attendee/171708452.

About Vireo Growth Inc.

Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry. This strategy drives our intense local market focus while leveraging the strength of a national portfolio. We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves. For more information about Vireo, visit www.vireogrowth.com.

Contact Information

Joe Duxbury
Chief Accounting Officer
investor@vireogrowth.com
(612) 314-8995


FAQ

When will Vireo Growth (VREOF) report Q4 and full year 2025 results?

Vireo Growth will report Q4 and full year 2025 results on March 17, 2026, before the market opens. According to the company, management will discuss results during a conference call that morning and provide an audio webcast for investors.

How can investors join the Vireo Growth (VREOF) earnings call on March 17, 2026?

Investors can join by dialing 1-800-715-9871 (US/Canada) or 1-646-307-1963 (International) and using conference ID 9471311. According to the company, a live audio webcast will also be available on its Investor Relations Events & Presentations page.

What time is Vireo Growth's (VREOF) conference call for Q4 2025 results?

The conference call is scheduled for 8:00 a.m. ET (7:00 a.m. CT)

Will Vireo Growth (VREOF) provide a webcast of the March 17, 2026 results call?

Yes. A live audio webcast will be available in the Investor Relations Events & Presentations section and via the supplied Q4 events link. According to the company, the webcast will stream simultaneously with the conference call for remote attendees.

What conference ID should I use to access Vireo Growth’s (VREOF) March 17, 2026 call?

Use conference ID 9471311 when dialing into the call. According to the company, that ID applies to both the US/Canada toll-free line and the international dial-in for the March 17, 2026 earnings discussion.
Vireo Growth Inc

OTC:VREOF

View VREOF Stock Overview

VREOF Rankings

VREOF Latest News

VREOF Latest SEC Filings

VREOF Stock Data

438.51M
762.00M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Minneapolis